eBM - Evidence Based Marketing Ltd. & Evidence Base About   |   Services   |   Client List   |   Contact    


Evidence Base
 


 

Evidence Base
    -   Background
    -   Portfolio Optimisation / Divestment
    -   Business Development / Acquisition
    -   Key Modules
    -   Value Add
            Portfolio Management
            Business Development / M+A

Strategic Consultancy

RX - OTC Switch

Strategic Partnerships
    -   Market Analysis
    -   Regulatory Advisory


 evidence-base.com - W3C Standards Compliant XHTML
 evidence-base.com - W3C Standards Compliant CSS

Evidence Based Marketing

EVIDENCE BASE

Value Add in Business Development / M+A Context
Delivers instant ability to evaluate and quantify any strategic option for sell or buy side mandate.

Provides instant financial and portfolio impact analysis and scenario planning vs. acquisition divestment.

Allows integrated historical investment and profitability analysis for any company and or brand in any geography.

Provides substantive future value analysis based on sales, historical investment and current brand consumer standing measures.

Provides accurate and instant brand and company financial benchmarking by category, by geography and on a consolidated global basis.

Identifies potential synergies and automatically incorporates into overall valuation.

Provides instant business development potential via detailed category and country gap analysis.

Provides instant business development potential via detailed category and country gap analysis.

Highlights antitrust issues and quantifies exposure for own and competitive bidders.

Adaptable to all sponsor agendas.

Greater accuracy vs. current asset valuation and synergy assessment.

Delivers greater accuracy vs. current asset development potential and next stage strategic development options.

Drives deal value optimisation.

Allows accelerated response times.

Generates improved productivity vs. internal / outsourced exec time.

Enables enhanced proactivity / reactivity vs. client prospecting.

Allows enhanced risk return vs. client prospecting.

Delivers enhanced investment prioritisation / divestment planning post acquisition.

Captures extensive expert consulting knowledge with all key industry players.

Evidence Base - Developing the Future Value Agenda for Business Development in Self Medication
 
  View Evidence Base Main Site  |   © 2006 Evidence Based Marketing Ltd.   |   Website by mykanjo.co.uk